Results 11 to 20 of about 1,502 (210)

Special immunobiologicals’ schedule applied to infants at a reference service in Ceará - [PDF]

Revista Brasileira em Promoção da Saúde, 2012
Objective: To analyze the vaccine schedule for preterm infants in a program of special immunobiologicals. Methods: A documental study conducted at a Reference Center of Special Immunobiologicals (CREATE) situated in a general hospital of tertiary care ...
Vera Lúcia Bezerra Oliveira, Gisele Nogueira de Moura, Joselany Áfio Caetano   +2 more
doaj   +3 more sources

Alternative potency tests for quality control of immunobiologicals: a critical review of the validation approach [PDF]

Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2020
Introduction: In addition to low reproducibility, in vivo potency tests used in the quality control of immunobiological products require too many animals, causing them significant pain and suffering.
Wildeberg Cal Moreira, Nathalia de Souza Machado, Jéssica Ferreira de Souza Freitas, Antônio Eugênio Castro Cardoso de Almeida, Wlamir Correa de Moura   +4 more
doaj   +9 more sources

Special immunobiologicals’ schedule applied to infants at a reference service in Ceará [PDF]

Revista Brasileira em Promoção da Saúde, 2010
Objective: To analyze the vaccine schedule for preterm infants in a program of special immunobiologicals. Methods: A documental study conducted at a Reference Center of Special Immunobiologicals (CREATE) situated in a general hospital of tertiary care in
Joselany Áfio Caetano, Gisele Nogueira de Moura, Vera Lúcia Bezerra Oliveira   +2 more
doaj   +2 more sources

Factors associated with vaccination coverage in children up to 15 months old, born in 2017-2018 in the city of Natal/RN, Brazil: a population-based survey [PDF]

Epidemiologia e Serviços de Saúde
Objective To estimate vaccination coverage and analyze factors associated with full vaccination among children up to 15 months old in the city of Natal-RN, Brazil.
Nayre Beatriz Martiniano de Medeiros, Isabelle Ribeiro Barbosa, Rita Barradas Barata, Ana Paula França, Ione Aquemi Guibu, José Cássio de Moraes, Carla Magda Allan Santos Domingues, Maria da Gloria Teixeira, Ana Clara Dantas de Souza, Eliene Roberta Alves Dos Santos, Mayonara Fabíola Silva Araújo, Clebson Verissimo da Costa Pereira, Ricardo Andrade Bezerra, Arthur Alexandrino, Fábia Cheyenne Gomes de Morais Fernandes, Adriana Ilha da Silva, Alberto Novaes Ramos Jr., Ana Paula França, Andrea de Nazaré Marvão Oliveira, Antonio Fernando Boing, Carla Magda Allan Santos Domingues, Consuelo Silva de Oliveira, Ethel Leonor Noia Maciel, Ione Aquemi Guibu, Isabelle Ribeiro Barbosa Mirabal, Jaqueline Caracas Barbosa, Jaqueline Costa Lima, José Cássio de Moraes, Karin Regina Luhm, Karlla Antonieta Amorim Caetano, Luisa Helena de Oliveira Lima, Maria Bernadete de Cerqueira Antunes, Maria da Gloria Teixeira, Maria Denise de Castro Teixeira, Maria Fernanda de Sousa Oliveira Borges, Rejane Christine de Sousa Queiroz, Ricardo Queiroz Gurgel, Rita Barradas Barata, Roberta Nogueira Calandrini de Azevedo, Sandra Maria do Valle Leone de Oliveira, Sheila Araújo Teles, Silvana Granado Nogueira da Gama, Sotero Serrate Mengue, Taynãna César Simões, Valdir Nascimento, Wildo Navegantes de Araújo   +45 more
doaj   +2 more sources

Immunobiologicals [PDF]

Journal of Medical Science And clinical Research, 2017
null null, Karthik R
openaire   +2 more sources

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug

Pharmaceuticals, 2022
The depth and versatility of siRNA technologies enable their use in disease targets that are undruggable by small molecules or that seek to achieve a refined turn-off of the genes for any therapeutic area.
Danielle de Brito e Cunha, Ana Beatriz Teixeira Frederico, Tamiris Azamor, Juliana Gil Melgaço, Patricia Cristina da Costa Neves, Ana Paula Dinis Ano Bom, Tatiana Martins Tilli, Sotiris Missailidis   +7 more
doaj   +1 more source

Immunobiology of cholangiocarcinoma [PDF]

JHEP Reports, 2019
Cholangiocarcinoma (CCA) represents a heterogeneous group of epithelial tumours that are classified according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). Although surgical resection and liver transplantation following neoadjuvant therapy are potentially curative options for a subset of patients with early-stage ...
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, Sumera Rizvi   +3 more
openaire   +3 more sources

Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis

Anais Brasileiros De Dermatologia, 2022
, Cynthia Cristina Ferreira Mota, André Luis Da Silva Hirayama   +2 more
exaly   +3 more sources

ANALYSIS OF THE PERSONNEL’S CONSISTENT READINESS FOR CHANGES AS ILLUSTRATED BY THE EXAMPLE OF AN EXPORT-ORIENTED BIOTECHNOLOGICAL ENTERPRISE

Фармация и фармакология (Пятигорск), 2021
The biotechnology industry is currently one of the most dynamically developing sectors of the pharmaceutical industry, that is why it requires improvement in the personnel management system aimed at increasing the flexibility and adaptability of the ...
E. V. Kazakova, V. P. Trukhin, I. A. Narkevich, I. I. Basakina   +3 more
doaj   +1 more source

Comparability assessment of the results of thiomersal quantification in adsorbed immunobiological medicinal products by colourimetry and by cold vapor atomic absorption spectrometry

Биопрепараты: Профилактика, диагностика, лечение, 2022
To ensure the quality of immunobiologicals, it is required to quantify the thiomersal preservative present in a number of them. The authors have previously developed an analytical procedure for thiomersal quantification in non-adsorbed immunobiological ...
O. N. Kolesnikova, V. E. Tregubova, O. B. Ustinnikova, A. A. Movsesyants   +3 more
doaj   +1 more source